Accessibility Menu
Cibus logo

Cibus(NASDAQ) CLXT

Current PriceN/A
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-99%
1 Year+3%
1 Month+24%
Cibus last closing stock price
MetricPriceDate
Last closeUSD 1.702026-07-24
Cibus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.03%USD 1.792026-07-17
1 month+24.09%USD 1.372026-06-24
3 month+13.33%USD 1.502026-04-24
Year to date-2.3%USD 1.742025-12-31
1 year+3.03%USD 1.652025-07-24
3 year-90.84%USD 18.552023-07-25
5 year-99.1%USD 188.502021-07-23
Since inception-99.7%USD 562.502017-07-20

Cibus Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.29M

Net Income (TTM)

-$102.18M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 2, 2023

CLXT News

soybeans in field

These Gene-Editing Pioneers Are Making Bold Bets in Agriculture

Maxx ChatskoJan 18, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cibus

Cibus develops plant traits that help farmers grow crops with fewer chemicals. Its technology also creates ingredients for companies seeking sustainable alternatives. These solutions aim to improve crop yields and reduce environmental impact.

Products and Services

  • Gene-edited crop traits: Traits for rice, canola, soybean, wheat, and alfalfa; enable higher yields and less chemical use.
  • Sustainable ingredients: Ingredients for consumer products, such as biofragrances, replacing fossil fuel-based inputs (included in 2025 revenue).
  • Trait development platform: RTDS platform for rapid, precise gene editing; licensed to seed companies.
  • Research collaborations: Contract research and development for agricultural partners; main revenue source in 2025.

Growth and Expansion

  • Streamlined focus in 2025 on rice herbicide tolerance and sustainable ingredients, consolidating operations in San Diego.
  • Expanded rice program partnerships in the US and Latin America in 2025; strategic advisory for India entry.
  • Advanced sustainable ingredients with pilot runs and collaboration with Procter & Gamble in 2025.
  • Achieved regulatory milestones in the US, Ecuador, and pending legislation in the EU during 2025.

What Makes Cibus Stand Out

Cibus uses a non-GMO gene editing approach, reducing regulatory barriers in many countries. Its royalty-based model leverages partners for commercialization, limiting capital needs. The company holds over 500 patents, supporting its competitive position in agricultural biotechnology.

Five Things You Need to Know

  • Revenue was $3.6 million in 2025, down 15% from 2024.
  • Net loss was $132.2 million in 2025, improved 53% from 2024.
  • Cash used in operations was $50.6 million in 2025, down 13% from 2024.
  • Customer A accounted for 76.8% of 2025 revenue; high customer concentration risk.

Bottom Line

Cibus has narrowed its focus to core crop traits and sustainable ingredients. The company remains early-stage, with commercial royalties yet to scale and ongoing funding needs.

AI Generated • Apr 16, 2026

Industry

Biotechnology

Sector

Health Care

Employees

118

CEO

Peter Beetham, PhD

Website

www.cibus.com

Headquarters

Roseville, MN 55113-1127, US

CLXT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

-1588.38%

Net Income Margin

-2384.11%

Return on Equity

-227.28%

Return on Capital

-177.74%

Return on Assets

-31.52%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$68.08M

EBITDA

-$27.66M

Operating Cash Flow

-$50.25M

Capital Expenditure

-$402.00K

Free Cash Flow

-$50.65M

Cash & ST Invst.

$30.33M

Total Debt

$32.11M

Cibus Performance Analysis

Cibus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 157,000-99.4%
20232023-12-31USD 1,817,0001057.3%
20242024-12-31USD 4,262,000134.6%
20252025-12-31USD 3,639,000-14.6%
Cibus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-9.8%
Q32025-09-30-34.1%
Q42025-12-3171.9%
Q12026-03-3159.0%
Cibus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -18.36-52.9%
20232023-12-31USD -25.9541.3%
20242024-12-31USD -10.83-58.3%
20252025-12-31USD -2.78-74.3%
Cibus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3054.5%
Q32025-09-3027.9%
Q42025-12-31-34.1%
Q12026-03-3144.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.68M

+62.6%

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

48

N/A

Net Income

-$21.22M

+54.7%

EBITDA

$1.20M

-26.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$30.33M

+28.6%

Total Debt

$32.11M

-9.9%

Accounts Receivable

$1.70M

+79.3%

Inventory

$0.00

N/A

Long Term Debt

$29.15M

-5.2%

Short Term Debt

$2.96M

-39.4%

Return on Assets

-31.52%

N/A

Return on Invested Capital

-21.94%

N/A

Free Cash Flow

-$11.60M

+4.3%

Operating Cash Flow

-$11.49M

+2.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HAPPHappiness Development Group Limited
$4.50+1.12%
TTCFQTattooed Chef, Inc.
$0.00-0.00%
MITCMeaTech 3D Ltd.
$3.34-1.47%
PMEPingtan Marine Enterprise Ltd.
$0.27-6.90%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About CLXT

What is the current price of Cibus?

Cibus is trading at N/A per share.

What is the 52-week range for Cibus?

Over the past 52 weeks, Cibus has traded between N/A and N/A.

How much debt does Cibus have?

As of the most recent reporting period, Cibus reported total debt of $276.15M.

How much cash does Cibus have on hand?

Cibus reported $30.33M in cash and cash equivalents in its most recent financial results.

What is Cibus’s dividend yield?

Cibus does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services